Lumina Pharmaceuticals CEO Cara Ferreira to Present at Discovery on Target Conference in September 2026

Boston, MA, September 15, 2026 – Lumina Pharmaceuticals, a clinical-stage radiopharmaceutical company advancing fibrin-targeting theranostic agents, today announced that Cara Ferreira, Ph.D., Chief Executive Officer, will participate in Discovery on Target 2026, taking place September 28 – October 1, 2026 at the Sheraton Boston in Boston, Massachusetts. Discovery on Target highlights transformative scientific and technological […]